4/A//SEC Filing
William Arsani 4/A
Accession 0001209191-23-048441
CIK 0001807120other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:13 PM ET
Size
10.4 KB
Accession
0001209191-23-048441
Insider Transaction Report
Form 4/AAmended
William Arsani
Director
Transactions
- Purchase
Common Stock
2021-03-30$20.00/sh+700,000$14,000,000→ 700,000 total(indirect: By Logos Global Master Fund LP) - Conversion
Common Stock
2021-03-30+1,217,627→ 1,217,627 total(indirect: By Logos Opportunities Fund II, L.P.) - Conversion
Common Stock
2021-03-30+814,874→ 814,874 total(indirect: By Logos SPV 1 LP)
Footnotes (4)
- [F1]All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately upon the closing of the Issuer's initial public offering, for no additional consideration at a rate of one share of Common Stock for each 1.63 shares of Preferred Stock, based on the conversion price currently in effect. The Preferred Stock has no expiration date.
- [F2]This Form 4 is being amended to correct the amount of securities beneficially owned by the Reporting Person. This error resulted in the misreporting of the amount of securities beneficially owned by the Reporting Person on subsequent reports.
- [F3]Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II") and Logos SPV 1 LP ("SPV 1"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. Logos Opportunities II GP LLC ("GP II") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001848372
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:13 PM ET
- Size
- 10.4 KB